IP Library Granted Patent US 7,914,509
Granted Patent B2
US 7,914,509 · App. 11/707,189 · Granted Mar 29, 2011

Ultrasound catheter

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,914,509
App. No.
11/707,189
Granted
Mar 29, 2011
Kind
B2
Abstract

The invention relates to a catheter system. The system comprises a catheter body having a chamber containing a low acoustic impedance medium. The catheter body includes an elongated body with an external surface and an ultrasound transducer having an external side between a first end and a second end. The ultrasound transducer is positioned over the external surface of the elongated body such that the first end is adjacent to the chamber.

Claims (15)

1. A method of delivering ultrasound energy and a drug solution to a treatment site, the method comprising:

positioning a guidewire through a clot at the treatment site;

advancing a sheath over the guidewire, such that at least a portion of the guidewire is positioned within a utility lumen defined by the sheath, wherein the sheath includes a drug delivery lumen having drug delivery ports;

removing the guidewire from the utility lumen;

passing a catheter through the utility lumen, the catheter including an ultrasound transducer;

delivering the drug solution to the treatment site through the drug delivery lumen and drug delivery ports;

delivering ultrasonic energy to the treatment site from the ultrasound transducer through the sheath; and

moving the ultrasound transducer within the sheath while the ultrasonic energy is being delivered to the treatment site.

2. The method of claim 1 , wherein the sheath is advanced through the clot.

3. The method of claim 1 , further comprising sensing a temperature at the treatment site during delivery of the ultrasound energy.

4. The method of claim 1 , wherein the drug solution is a clot dissolution compound.

5. The method of claim 1 , wherein the drug solution is delivered with a substantially even flow through a plurality of drug delivery ports formed in the drug delivery lumen.

6. The method of claim 1 , wherein:

the catheter includes the ultrasound transducers; and

the ultrasonic energy is delivered to the treatment site from the plurality of ultrasound transducers.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded May 15, 2013
From: HERCULES TECHNOLOGY II, L.P.
To: EKOS CORPORATION
Reel/Frame 030421/0867 →
SECURITY AGREEMENT Recorded Jul 16, 2007
From: EKOS CORPORATION
To: HERCULES TECHNOLOGY II, L.P.
Reel/Frame 019550/0881 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2007
From: BENNETT, FREDERICK J.; ZHANG, JOHN; LICHTTENEGGER, GARY; RODRIGUEY, JAMES E.; TACHIBANA, KATSURO
To: EKOS CORPORATION
Reel/Frame 019007/0919 →
MERGER Recorded Feb 15, 2007
From: EKOS CORPORATION, A WASHINGTON CORPORATION
To: EKOS CORPORATION, A DELAWARE CORPORATION
Reel/Frame 019014/0562 →